Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis)
Diego Orsini(San Gallicano Hospital), Antonio Costanzo(Humanitas University), Luca Bianchi(University of Rome Tor Vergata), Angelo Valerio Marzano(University of Milan), Giovanni Paolino(Vita-Salute San Raffaele University), Francesco Loconsole(University of Bari Aldo Moro), Edoardo Mortato(University of Bari Aldo Moro), Maria Esposito(University of L'Aquila), Annunziata Dattola(University of Rome Tor Vergata), Luigi Gargiulo(Humanitas University), Matteo Megna(University of Padua), Claudia Lasagni(University of Modena and Reggio Emilia), Annamaria Offidani(Marche Polytechnic University), Francesco Cusano(Azienda Ospedaliera G.Rummo), Piergiorgio Malagoli(IRCCS Policlinico San Donato), Antonio Giovanni Richetta(Sapienza University of Rome), Anna Campanati(Marche Polytechnic University), Pina Brianti(Vita-Salute San Raffaele University), Dario Buononato(University of Campania "Luigi Vanvitelli"), Paolo Dapavo(University of Turin), Chiara Assorgi(San Gallicano Hospital), Marina Venturini(University of Brescia), Santo Raffaele Mercuri(Vita-Salute San Raffaele University), Vincenzo Maione(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Valentina Dini(University of Pisa), Anna Balato(University of Naples Federico II), Luca Potestio(University of Naples Federico II), Maria Concetta Fargnoli(University of L'Aquila), Martina Burlando(Ospedale Policlinico San Martino), Luciano Ibba(Humanitas University), Pietro Quaglino(Department of Medical Sciences), Giacomo Caldarola(Università Cattolica del Sacro Cuore), Andrea Carugno(University of Insubria), Paolo Sena(Ospedale Papa Giovanni XXIII), Alessandro Giunta(University of Rome Tor Vergata), Clara De Simone(IRCCS San Camillo Hospital), Alessandra Narcisi(IRCCS Humanitas Research Hospital), Francesca Maria Gaiani(IRCCS Policlinico San Donato), Elena Campione(University of Rome Tor Vergata), Paolo Gisondi(University of Verona), Aurora Parodi(Ospedale Policlinico San Martino), Francesca Romano(Ospedale Antonio Cardarelli), Giovanni Pellacani(Sapienza University of Rome), Carlo Giovanni Carrera(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Martina Maurelli(University of Verona)
Cited by 34
Related Papers
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
|JAMA Dermatology|2015|452
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
|European Journal of Cancer|2017|449
The Impact of In Vivo Reflectance Confocal Microscopy for the Diagnostic Accuracy of Melanoma and Equivocal Melanocytic Lesions
|Journal of Investigative Dermatology|2007|444